Dysgraphia

Summary

Dysgraphia (MONDO:0003038) is a disease and 3 clinical trials. A subtype of writing disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	dysgraphia
Mondo ID	MONDO:0003038
DOID	DOID:4540
NCIT	C182452
UMLS	C0234144
MedGen	115942
Is cancer (heuristic)	no

Also known as: dysgraphia · dysgraphia (disease)

Data availability: 1 HPO phenotype.

Disease family

Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disorder › mental disorder › developmental disorder of mental health › specific developmental disorder › learning disability › writing disorder › dysgraphia

Related subtypes (1): agraphia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01927302	Not specified	COMPLETED	Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery
NCT03699787	Not specified	COMPLETED	Graphomotor Intervention Program for Handwriting Difficulties Prevention in Preschool Age
NCT03699800	Not specified	COMPLETED	Graphomotor Intervention Program for Handwriting Difficulties Prevention in School-Age